preliminary results from this new protocol , moderate-dose mtx , bleomycin , doxorubicin , cyclophosphamide , vincristine and dexamethasone ( m-bacod ) , as of november 1985 in 80 patients , show cr in 60 ( 75 % ) patients .
C0010583
cyclophosphamide
C0083304
m-bacod